Barlage Lara, Seifert Roland
Institute of Pharmacology, Hannover Medical School, D-30625, Hannover, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5195-5211. doi: 10.1007/s00210-024-03571-0. Epub 2024 Nov 12.
Online pharmacies are popular worldwide. In Germany, there were 150 active online pharmacies in 2022. As the competition is therefore fierce and new customers need to be acquired, some of these online pharmacies create catalogues that advertise products in self-medication to attract the interest of potential customers. This study analyzed the allergy, cold, and gastrointestinal tract categories from the summer/spring 2023 catalogues of two different online pharmacies in Germany. A comparison of the active ingredients in both catalogues and an analysis of the product's conformity with the German AWMF (Association of the Scientific Medical Societies in Germany) guidelines as well as international guidelines were carried out. In medicine, guidelines serve as evidence-based decision-making aids tools to ensure adequate patient care. The online catalogue of online pharmacy 1 showed conformity of 65% with AWMF guidelines, and the online catalogue of online pharmacy 2 showed conformity of 59% with AWMF guidelines. The online catalogue of online pharmacy 1 showed conformity of 44% with international guidelines, and the online catalogue of online pharmacy 2 showed conformity of just only 17% with international guidelines. Thus, there is a substantial lack of conformity of online pharmacy self-medication catalogues with national and international guidelines. For several indication areas including market-relevant rhinosinusitis and irritable bowel syndrome, consensus between AWMF and international guidelines was poor. The lack of evidence-based presentation of online pharmacy catalogues constitutes a risk for consumer safety. This risk must be assessed in future studies, for example by studies on intoxications caused by self-medication that is non-compliant with guidelines. Our results also underline the necessity of a stricter surveillance of the German self-medication market.
在线药房在全球都很受欢迎。在德国,2022年有150家活跃的在线药房。由于竞争激烈且需要获取新客户,其中一些在线药房制作了宣传自我药疗产品的目录,以吸引潜在客户的兴趣。本研究分析了德国两家不同在线药房2023年春夏目录中的过敏、感冒和胃肠道类别。对两个目录中的活性成分进行了比较,并分析了产品是否符合德国AWMF(德国科学医学协会)指南以及国际指南。在医学领域,指南作为循证决策辅助工具,以确保为患者提供充分的护理。在线药房1的在线目录显示与AWMF指南的符合率为65%,在线药房2的在线目录显示与AWMF指南的符合率为59%。在线药房1的在线目录显示与国际指南的符合率为44%,在线药房2的在线目录显示与国际指南的符合率仅为17%。因此,在线药房自我药疗目录与国家和国际指南存在严重不符。对于包括与市场相关的鼻窦炎和肠易激综合征在内的几个适应症领域,AWMF与国际指南之间的共识较差。在线药房目录缺乏循证呈现对消费者安全构成风险。这种风险必须在未来的研究中进行评估,例如通过对不符合指南的自我药疗导致的中毒情况进行研究。我们的结果还强调了对德国自我药疗市场进行更严格监管的必要性。